ARCHIVES

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993

In Brief: Survey Finds Americans Misinformed About Leading Cause Of Cancer Death

July 10, 1998

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

June 28, 2013

Reynolds Unveils New Cigarette ; Cullen, Others Skeptical

September 18, 1987

Fifty-Nine CCOP Awards Made; Payline 250, Six Funded as Exceptions

May 27, 1983

Book Review: In Memoir Written to Avoid Doing Time, Disgraced Exec Reflects on BMS Heyday

July 6, 2012